GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by EverSource Wealth Advisors LLC

EverSource Wealth Advisors LLC boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 30.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,094 shares of the company’s stock after buying an additional 484 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in GE HealthCare Technologies were worth $164,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Harbour Investments Inc. increased its holdings in shares of GE HealthCare Technologies by 4.3% in the 3rd quarter. Harbour Investments Inc. now owns 3,164 shares of the company’s stock valued at $297,000 after acquiring an additional 131 shares during the last quarter. OneDigital Investment Advisors LLC boosted its holdings in GE HealthCare Technologies by 7.5% in the third quarter. OneDigital Investment Advisors LLC now owns 13,798 shares of the company’s stock valued at $1,295,000 after purchasing an additional 961 shares in the last quarter. Empowered Funds LLC increased its stake in GE HealthCare Technologies by 30.7% in the third quarter. Empowered Funds LLC now owns 23,470 shares of the company’s stock valued at $2,203,000 after purchasing an additional 5,512 shares during the last quarter. Natixis Advisors LLC raised its holdings in GE HealthCare Technologies by 36.7% during the third quarter. Natixis Advisors LLC now owns 380,071 shares of the company’s stock worth $35,670,000 after purchasing an additional 102,000 shares in the last quarter. Finally, Mutual of America Capital Management LLC lifted its position in shares of GE HealthCare Technologies by 5.0% during the 3rd quarter. Mutual of America Capital Management LLC now owns 56,349 shares of the company’s stock worth $5,288,000 after buying an additional 2,696 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $82.47 on Tuesday. The stock has a market capitalization of $37.71 billion, a P/E ratio of 19.05, a P/E/G ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80. The company’s fifty day moving average is $87.27 and its two-hundred day moving average is $86.12.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Citigroup lifted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their target price for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.